Side-by-side comparison of AI visibility scores, market position, and capabilities
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
€75.9B revenue FY2024 (+3% comparable); Q3 FY2025 €19.4B (+5% comparable); 3-7% comparable growth expected FY2025; automation business recovering Q3; manufacturing automation leader
Siemens is a global technology conglomerate specializing in automation, digitalization, and electrification solutions for industrial manufacturing, infrastructure, and energy sectors. The company serves industrial enterprises, utilities, and infrastructure operators with products and services spanning factory automation, process control, building technologies, mobility solutions, and digital industries software. Siemens creates value through its integrated portfolio of hardware, software, and services that optimize productivity, efficiency, and sustainability across the entire industrial value chain.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.